Sample type | Number of samples | Mean viral load±SD in log10copies/mL | Mean log10 viral load difference±SD in log10copies/mL | |
---|---|---|---|---|
ExaVir Load V3 | Abbott m2000rt | |||
All samples | 629 | 3.98±1.3 | 4.19±1.3 | 0.22±0.3 |
ART Status | ||||
Naïve (baseline at WK00) | 327 | 5.07±0.6 | 5.33±0.5 | 0.25±0.3 |
Experienced (WK04) | 302 | 2.79±0.5 | 2.97±0.6 | 0.19±0.4 |
Subtype at WK00 (n=319)* | ||||
C | 313 | 5.08±0.6 | 5.33±0.4 | 0.25±0.3 |
Non-C | 6 | 5.05±0.5 | 5.3±0.4 | 0.25±0.3 |
DRMs at WK00 (n=319)* | ||||
Wild type (no DRM) | 308 | 5.07±0.6 | 5.32±0.5 | 0.25±0.3 |
NRTI mutations | 6 | 5.41±0.3 | 5.55±0.01 | 0.15±0.3 |
NNRTI mutations | 5 | 5.26±0.2 | 5.62±0.2 | 0.36+0.2 |
*Genotyping performed only in baseline samples.
ART, antiretroviral therapy; DRM, drug-resistant mutations, NNRTI, non-nucleoside reverse transcriptase inhibitors; NRTI, nucleoside reverse transcriptase inhibitors; RT, reverse transcriptase; VL, viral load.